Coronavirus disease-2019 (COVID-19) is a novel respiratory disease induced by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It remains poorly understood how …

The reason why most individuals with COVID-19 have relatively limited symptoms while
other develop respiratory distress with life-threatening complications remains unknown …

Abstract The 2019 coronavirus disease (COVID-19) outbreak caused by the SARS-CoV-2
virus is an ongoing global health emergency. However, the virus' pathogenesis remains …

Background: Dysregulated immune responses to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are thought to underlie the progression of coronavirus disease …

Covid-19 features a delayed onset of critical illness occurring approximately one week from
the beginning of symptoms, which corresponds to the bridging of innate and adaptive …

Understanding the processes of immune regulation in patients infected with the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for improving treatment …

We pursued a study of immune responses in coronavirus disease 2019 (COVID-19) and
influenza patients. Compared to patients with influenza, patients with COVID-19 exhibited …

Abstract Coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus named
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with some patients …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) can trigger a cytokine
storm in the pulmonary tissue by releasing various types of mediators, leading to acute …

Cumulative data link cytokine storms with coronavirus disease 2019 (COVID-19) severity.
The precise identification of immune cell subsets in bronchoalveolar lavage (BAL) and their …